Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03465371
What this trial is testing

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

Who this might be right for
Psychosis
Center for Social Innovation, Massachusetts 349
Post-approval studies (Phase 4)Study completedNCT00351000
What this trial is testing

Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus

Who this might be right for
Schizophrenia
North Suffolk Mental Health Association 24
Early research (Phase 1)Study completedNCT02411526
What this trial is testing

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Zogenix, Inc. 60
Not applicableStudy completedNCT04941352
What this trial is testing

Motivational Interviewing in Patients With Schizophrenia

Who this might be right for
Motivational InterviewsSchizophrenia
Pamukkale University 40
Testing effectiveness (Phase 2)Study completedNCT03425552
What this trial is testing

A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment

Who this might be right for
Schizophrenia
Pharmathen S.A. 70
Not applicableActive Not RecruitingNCT07571148
What this trial is testing

Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users

Who this might be right for
Schizophrenia
Bristol-Myers Squibb 6,876
Post-approval studies (Phase 4)Study completedNCT01041274
What this trial is testing

DECIFER: Depression and Citalopram In First Episode Recovery

Who this might be right for
SchizophreniaSchizophreniform Disorder
NYU Langone Health 95
Not applicableUnknownNCT04230590
What this trial is testing

Health Outcomes Via Positive Engagement in Schizophrenia

Who this might be right for
Schizophrenia Spectrum Disorders
Institute of Mental Health, Singapore 100
Not applicableStudy completedNCT04546178
What this trial is testing

Psychotherapy for Psychosis, Adverse Events, and Substance Misuse

Who this might be right for
Psychotic DisordersStress Disorders, TraumaticSubstance Use
Nova Scotia Health Authority 19
Early research (Phase 1)Study completedNCT00783185
What this trial is testing

Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment

Who this might be right for
Psychotic DisordersMarijuana AbuseIntervention
University of Konstanz 50
Not applicableStudy completedNCT01216891
What this trial is testing

Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Research Foundation for Mental Hygiene, Inc. 65
Not applicableStudy completedNCT07436481
What this trial is testing

The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of Patients

Who this might be right for
Psychotic Disorder
Natalia Dewi Wardani, MD 80
Not applicableStudy completedNCT00695708
What this trial is testing

Training-induced Cerebral Reorganization in Schizophrenia

Who this might be right for
Schizophrenia
University of Konstanz 60
Testing effectiveness (Phase 2)Study completedNCT07038876
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Who this might be right for
Schizophrenia
MapLight Therapeutics 307
Early research (Phase 1)Study completedNCT01090440
What this trial is testing

Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects

Who this might be right for
Schizophrenia
GlaxoSmithKline 16
Not applicableNot Yet RecruitingNCT07710989
What this trial is testing

LIFU Effects & Outcomes: Mechanisms Evaluating Striatal Systems Imaging (LEO MESSI)

Who this might be right for
SchizophreniaAuditory Hallucinations
University of California, San Francisco 12
Early research (Phase 1)UnknownNCT03469089
What this trial is testing

Touchscreen-based Cognitive Tests in Healthy Volunteers

Who this might be right for
Cognitive SymptomSchizophrenia
University of Eastern Finland 16
Testing effectiveness (Phase 2)Ended earlyNCT04975035
What this trial is testing

A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

Who this might be right for
Schizophrenia
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Not applicableLooking for participantsNCT03911726
What this trial is testing

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 140
Testing effectiveness (Phase 2)Study completedNCT00768326
What this trial is testing

Efficacy of Lu 31-130 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 280
Next Page